Monnerie Hubert, Esquenazi Susana, Shashidhara Shalini, Le Roux Peter D
Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania 19107, USA.
Neurol Res. 2005 Jul;27(5):525-32. doi: 10.1179/016164105X40020.
The presence of beta-amyloid (betaA) deposition, induction of reactive gliosis and dystrophic neurites, is a characteristic feature of neuritic plaques in Alzheimer's disease. In vitro, betaA-exposed astrocytes become reactive, similar to astrocytes in contact with betaA plaques in vivo. How betaA-exposed reactive astrocytes support neuron process growth, however, is not well defined. Therefore, we used neuron/astrocyte co-cultures in which astrocytes had been grown on betaA, to assess whether process growth was altered.
Purified rat cortical astrocytes were plated on the betaA peptide's neurotoxic fragment (25-35), the scrambled (35-25) peptide, or poly-D-lysine alone and grown to confluency before mouse cortical neurons were seeded at low density onto the astrocyte monolayer. Cell survival was assessed using trypan blue, lactate dehydrogenase release and propidium iodide. Process growth was analyzed using specific antibodies against MAP2 and the 200 kDa neurofilament subunit (NF-H) to identify dendrites and axons, respectively.
betaA-exposed astrocytes changed dramatically from their flat polygonal shape into stellate process-bearing morphology. Viability however, was not affected. Immunocytochemical analysis of neuronal processes using anti-MAP2 and anti-NF-H, demonstrated that betaA (25-35)induced reactive astrocytes had an altered ability to support dendrite and axon growth after 3 days in vitro. Indeed, primary dendrite number and axon length were decreased by 30 and 26%, respectively, compared with control astrocytes, whereas individual primary dendrite length increased by 20%. Astrocyte support of dendritic branching, however, was not affected by betaA.
We conclude that an astrocyte reaction to betaA may contribute, in part, to neuronal dystrophy associated with betaA plaques.
β-淀粉样蛋白(βA)沉积、反应性胶质增生和营养不良性神经突的出现是阿尔茨海默病中神经炎性斑块的特征性表现。在体外,暴露于βA的星形胶质细胞会发生反应,类似于体内与βA斑块接触的星形胶质细胞。然而,暴露于βA的反应性星形胶质细胞如何支持神经元突起生长尚不清楚。因此,我们使用神经元/星形胶质细胞共培养体系,其中星形胶质细胞在βA上生长,以评估突起生长是否发生改变。
将纯化的大鼠皮质星形胶质细胞接种在βA肽的神经毒性片段(25-35)、 scrambled(35-25)肽或单独的聚-D-赖氨酸上,培养至汇合,然后将小鼠皮质神经元以低密度接种到星形胶质细胞单层上。使用台盼蓝、乳酸脱氢酶释放和碘化丙啶评估细胞存活情况。使用针对MAP2和200 kDa神经丝亚基(NF-H)的特异性抗体分别鉴定树突和轴突,分析突起生长情况。
暴露于βA的星形胶质细胞从扁平多边形形态显著转变为带有星状突起的形态。然而,细胞活力未受影响。使用抗MAP2和抗NF-H对神经元突起进行免疫细胞化学分析表明,在体外培养3天后,βA(25-35)诱导的反应性星形胶质细胞支持树突和轴突生长的能力发生了改变。实际上,与对照星形胶质细胞相比,初级树突数量和轴突长度分别减少了30%和26%,而单个初级树突长度增加了20%。然而,βA对星形胶质细胞支持树突分支的作用没有影响。
我们得出结论,星形胶质细胞对βA的反应可能部分导致了与βA斑块相关的神经元营养不良。